David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$997M |
| 2 |
Meta Platforms (Facebook)
META
|
+$626M |
| 3 |
Microsoft
MSFT
|
+$482M |
| 4 |
T-Mobile US
TMUS
|
+$416M |
| 5 |
Uber
UBER
|
+$350M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$547M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$490M |
| 3 |
Johnson & Johnson
JNJ
|
+$444M |
| 4 |
Apple
AAPL
|
+$435M |
| 5 |
Accenture
ACN
|
+$378M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.7% |
| 2 | Consumer Discretionary | 8.8% |
| 3 | Healthcare | 8.52% |
| 4 | Financials | 6% |
| 5 | Industrials | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
PUT
Li Auto
LI
$11.9B
| $1.05M | ﹤0.01% |
30,000
-251,600
| -89% | -$7.08M |
|
|
ITOS
2927
DELISTED
iTeos Therapeutics
ITOS
| $1.05M | ﹤0.01% |
79,482
+6,816
| +9% | +$97.2K |
|
|
KALV
2928
DELISTED
KalVista Pharmaceuticals
KALV
| $1.05M | ﹤0.01% |
116,862
+71,198
| +156% | +$656K |
|
|
PWSC
2929
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $1.05M | ﹤0.01% |
54,938
-465,117
| -89% | -$8.89M |
|
2930
Vital Farms
VITL
$470M
| $1.05M | ﹤0.01% |
87,557
+42,232
| +93% | +$590K |
|
2931
CALL
YPF Sociedad Anonima ADS
YPF
$19.7B
| $1.05M | ﹤0.01% |
70,500
-52,500
| -43% | -$637K |
|
2932
Wintrust Financial
WTFC
$10.3B
| $1.05M | ﹤0.01% |
14,408
-79,278
| -85% | -$5.41M |
|
|
OPI
2933
DELISTED
Office Properties Income Trust
OPI
| $1.05M | ﹤0.01% |
+135,745
| New | +$1.03M |
|
2934
Crescent Energy
CRGY
$4.42B
| $1.04M | ﹤0.01% |
100,086
+24,709
| +33% | +$265K |
|
|
EOCW
2935
DELISTED
Elliott Opportunity II Corp.
EOCW
| $1.04M | ﹤0.01% |
100,399
| – | – |
|
2936
Watsco Inc
WSO
$13B
| $1.04M | ﹤0.01% |
2,717
-28,834
| -91% | -$9.78M |
|
2937
ICICI Bank
IBN
$108B
| $1.03M | ﹤0.01% |
44,783
-261,171
| -85% | -$5.91M |
|
2938
PUT
Yeti Holdings
YETI
$3.05B
| $1.03M | ﹤0.01% |
26,600
-67,800
| -72% | -$2.63M |
|
|
SII
2939
Sprott
SII
$3.52B
| $1.03M | ﹤0.01% |
31,800
-1,500
| -5% | -$51.8K |
|
2940
Prudential
PUK
$35.1B
| $1.03M | ﹤0.01% |
+36,317
| New | +$1.04M |
|
2941
Tredegar Corp
TG
$271M
| $1.03M | ﹤0.01% |
+154,100
| New | +$1.22M |
|
2942
Stanley Black & Decker
SWK
$15.1B
| $1.03M | ﹤0.01% |
10,950
-381,717
| -97% | -$31.6M |
|
2943
Geron
GERN
$989M
| $1.03M | ﹤0.01% |
319,611
-1,324,777
| -81% | -$3.77M |
|
2944
CALL
MarineMax
HZO
$1.15B
| $1.02M | ﹤0.01% |
30,000
| – | – |
|
|
2945
PUT
MarineMax
HZO
$1.15B
| $1.02M | ﹤0.01% |
30,000
| – | – |
|
|
ALCYU
2946
DELISTED
Alchemy Investments Acquisition Corp 1 Units
ALCYU
| $1.02M | ﹤0.01% |
+100,000
| New | +$1.02M |
|
2947
PUT
Tandem Diabetes Care
TNDM
$1.49B
| $1.02M | ﹤0.01% |
+41,700
| New | +$1.34M |
|
2948
Saic
SAIC
$5.39B
| $1.02M | ﹤0.01% |
+9,093
| New | +$944K |
|
|
BUJAU
2949
DELISTED
Bukit Jalil Global Acquisition 1 Ltd. Unit
BUJAU
| $1.02M | ﹤0.01% |
+100,000
| New | +$1.02M |
|
2950
ESAB
ESAB
$5.11B
| $1.02M | ﹤0.01% |
15,295
-2,277
| -13% | -$138K |
|
Similar funds
David Shaw's Q2 2023 Portfolio in Review
As of Q2 2023, David Shaw held 4,841 positions worth $97.9B, up 4.8% from $93.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw withdrew a net $4.46B in Q2 2023, closing 639 positions and reducing 1,586 holdings. Its most notable exit was Shaw Communications Inc., an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Oracle worth $217M.
- David Shaw's largest Q2 2023 buy was Oracle: 1,825,762 shares worth $217M.
- David Shaw added most to NVIDIA in Q2 2023, an estimated $997M increase.
- David Shaw's biggest Q2 2023 reduction was Visa, cutting an estimated $547M.
- David Shaw fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $152M.
- David Shaw's ten largest holdings make up 12% of its $97.9B portfolio in Q2 2023.
- David Shaw opened 467 new positions and closed 639 in Q2 2023.
- David Shaw's portfolio value rose 4.8% quarter-over-quarter to $97.9B.
Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.